New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?
| Author | Andrea Messori | en |
| Author | Valeria Fadda | en |
| Author | Roberta Gatto | en |
| Author | Dario Maratea | en |
| Author | Sabrina Trippoli | en |
| Issued Date | 2014-09-30 | en |
| Abstract | Background: After an acute coronary syndrome, dual antiplatelet therapy with clopidogrel plus aspirin is still a standard of care, but several new approaches have been investigated. | en |
| DOI | https://doi.org/ | en |
| Keyword | Anticoagulants | en |
| Keyword | Acute Coronary Syndrome | en |
| Keyword | Rivaroxaban | en |
| Keyword | Ticagrelor | en |
| Publisher | Brieflands | en |
| Title | New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments? | en |
| Type | Brief Report | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- icrj-08-124.pdf
- Size:
- 747.11 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF